Coral Laboratories: Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14 2024 Pursuant To Regulation 30 (Read With Part A Of Schedule III) The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and other applicable provisions the Board of Directors of the Company in its meeting held on Thursday 14th November 2024 at the Corporate Office of the Company situated at 3B Patanwala Compound Opp. Shreyas Cinema L.B.S. Marg Ghatkopar (W) Mumbai- 400086 at 2:30 P.M has inter alia considered and approved: 1. The Unaudited Standalone Financial Results along with Statement of Asset & Liabilities and Cash Flow Statement for the quarter and half year ended September 30 2024 and took note of the Limited Review Report submitted by M A Parekh & Associates Statutory Auditor of the Company.